The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer

Clinical and Translational Oncology

Volumn 10, Issue 3, 2008, Pages 175-179

  Davies, Mark ^a   Arumugam, Ponnandai J ^a   Shah, Varsha I ^a   Watkins, Alun ^a   Morgan, Andrew Roger ^a   Carr, Nicholas D ^a   Beynon, John ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Cytokeratin; Micrometastasis

Indexed keywords

CYTOKERATIN; CYTOKERATIN AE1; CYTOKERATIN AE3; PANCYTOKERATIN; KERATIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MORTALITY; PREVALENCE; PROGNOSIS; SURVIVAL RATE; VASCULAR TUMOR; ADENOCARCINOMA; COLORECTAL TUMOR; LYMPH NODE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 45549096049     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-008-0176-y     Document Type: Article

References (24)

1. Office for National Statistics (2000) Health statistics Quarterly 6. ONS, London, Summer
2. Cohen AM, Tremiterra S, Candela F et al (1991) Prognosis of node-positive colon cancer. Cancer 67:1859-1861
3. McArdle CS, Hole D, Hansell D et al (1990) Prospective study of colorectal cancer in the West of Scotland: Ten year follow up. Br J Surg 77:280-282
4. Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: Recommendations for a minimum number of recovered lymph nodes based on predictive possibilities. Am J Surg Pathol 26:179-189
5. Haboubi NY, Clark P, Kaftan SM et al (1992) The importance of Xylene clearance and immunohistochemistry in the accurate staging of colorectal cancer. J R Soc Med 85:386-388
6. Wyk QV, Hosie KB, Balsitis M (2000) Histopathological detection of lymph node metastases from colorectal carcinoma. J Clin Pathol 53:685-687
7. Doglioni C, Dell'Orto P, Zanetti G et al (1990) Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological condition. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 416:479-490
8. Xu X, Roberts SA, Pasha TL, Zhang PJ (2000) Undesirable cytokeratin immunoreactivity of native non epithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Path Lab 124:1310-1313
9. Moertel CG, Fleming TR, MacDonald JS et al (1989) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358
10. Impact B2 investigators (1999) Efficacy of adjuvant fluorouracil and folinic acid in B 2 colon cancer. J Clin Oncol 17:1356-1363
11. Adell G, Boeryd B, Franlund B (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: An immunohistochemical study. Eur J Surg 162:637-642
12. Greenson JK, Isenhart CE, Rice R et al (1994) Identification of Occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 73:563-569
13. Cutait R, Alves VA, Lopes LC et al (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917-920
14. Jeffers MD, O'Dowd GM, Mulcahy H et al (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal cancer. J Pathol 172:183-187
15. Clarke G, Ryan E, Keane JC et al (2000) The detection of cytokeratins in lymph nodes of Dukes B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 12:549-552
16. Broll R, Schauer V, Schimmelpenning H et al (1997) Prognostic relevance of Occult tumour cells in lymph nodes of colorectal carcinomas: An immunohistochemical study. Dis Colon Rectum 40:1465-1471
17. Bertoglio S, Percivale P, Gambini C et al (1997) Cytokeratin immunostaining reveals micrometastasis in negative haematoxylin-eosin lymph nodes of resected stage 1-2(pT2-pT3) colorectal cancer. J Chemother 9:119-120
18. Nakanishi Y, Ochiai A, Yamauchi Y et al (1999) Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology 57:276-280
19. Garcia-Saenz J, Saenz M, Gonzalaz L et al (2006) Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma. Clin Trans Oncol 8:676-680
20. Bilchik A, Hoon D, Saha S et al (2007) Prognostic impact of micrometastases in colon cancer: Interim results of a prospective multicenter trial. Ann Surg 246:568-575
21. Colpaert C, Vermeulen P, Jeuris W et al (2001) Early distant relapse in node negative breast cancer patients is not predicted by occult axillary lymph nodes metastases but by the feature of the primary tumour. J Pathol 193:442-449
22. Nasser IA, Lee AK, Bosari S et al (1993) Occult axillary lymph node metastases in node negative breast carcinoma. Hum Pathol 24:950-957
23. Doekhie F, Kuppen P, Peeters K et al (2006) Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer. Eur J Surg Oncol 32:253-258
24. Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ (2007) Is occult lymph node disease in colorectal cancer patients clinically significant?: A review of the relevant literature. J Mol Diagn 9:563-571